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Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.03.051Background: Vasopressin may be a potential cause of spasm in both the radial artery
and the internal thoracic artery. This study compared the vasopressin-induced
contraction and the effects of milrinone, nitroglycerin, and nitroprusside in vaso-
pressin-induced contraction between the human radial artery and the internal tho-
racic artery to find effective antispastic methods for arterial grafts.
Methods: Concentration-contraction (normalized as force gram produced by each
millimeter of the circumference tissue of the artery) curves for vasopressin with or
without pretreatment of vasodilators and concentration-relaxation curves for the
vasodilators listed were established in the human radial artery (n 107) and internal
thoracic artery (n  122) segments.
Results: Vasopressin induced a greater contraction in the radial artery than in the
internal thoracic artery (1.9 0.2 g/mm vs 0.6 0.1 g/mm, P .001) with a higher
sensitivity (lower EC50: 9.28  0.11 vs 8.91  0.05 log10M, P  .006).
Milrinone was less potent than nitroglycerin and nitroprusside with higher EC50 (P
 .05) in both the internal thoracic artery and radial artery. Pretreatment with
milrinone and nitroprusside significantly inhibited vasopressin contraction in the
internal thoracic artery but had little effect in the radial artery. Pretreatment with
nitroglycerin did not significantly inhibit the maximum vasopressin contraction in
either the internal thoracic artery or radial artery.
Conclusion: The radial artery is more prone to develop spasm related to vasopressin
than is the internal thoracic artery, and the effect of vasodilators in vasopressin-
induced contraction is different in the radial artery from that in the internal thoracic
artery. A more significant prophylactic antispastic effect of milrinone and nitro-
prusside is demonstrated in the internal thoracic artery than in the radial artery.
Therefore, more intensive antispastic treatment is necessary in the radial artery than
in the internal thoracic artery during coronary artery bypass grafting.
Because of the superior results of the internal thoracic artery (ITA)in coronary artery bypass grafting (CABG),1 other arterial graftssuch as the radial artery (RA) have been used as coronary bypassgrafts. The revival of the RA is largely based on the fact thatarterial grafts have superior long-term patency to the saphenousvein,2 and the success of RA grafting is because of the improved
techniques in harvesting and preservation of the vessel.3-6 Recently, a 5-year
follow-up study of the RA graft showed an impressive 83% patency rate.5 However,
the RA is known to have a higher incidence of spasm during harvesting. Although
calcium antagonists have been used clinically to relieve RA spasm and their effect
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CSPhas been studied,7 pharmacologic prophylaxis for perioper-
ative RA vasospasm remains a challenge because of the
complexity of the cause of vasospasm.
Vasopressin (VP) is a neuropeptide that promotes reab-
sorption of water in renal tubular cells through V2 receptors
and produces constriction of vascular smooth muscle
through V1 receptors.8 VP has been regarded as one of the
most potent vasoconstrictors in coronary circulation9 and is
capable of sensitizing the vascular smooth muscle to the
effects of norepinephrine even at low concentration.8 Sim-
ilar to epinephrine and norepinephrine, which are signifi-
cantly elevated during cardiopulmonary bypass, plasma VP
concentration has been demonstrated to dramatically in-
crease during cardiopulmonary bypass surgery.10,11 Even
more important, the elevation of the concentration of VP is
more significant during the perioperative period in patients
undergoing CABG than in patients undergoing valve re-
placement.11 As reported by Philbin and colleagues,11 VP
(antidiuretic hormone) levels increased from a control value
of 4.3  1.5 pg/mL to 13.0  3.3 pg/mL with surgical
stimulation. During cardiopulmonary bypass, the VP levels
increased to a peak of 23.7  3.6 pg/mL at 30 minutes and
were decreasing at 45 minutes. During CABG, the concen-
tration of VP remains dramatically high, and it gradually
decreases until 2 hours after surgery.
We recently demonstrated that VP is a strong vasocon-
strictor in the human ITA.12 Therefore, VP is a potential
spasmogen for RA spasm in CABG. However, the VP-
induced contraction has not been reported in the RA, and the
interaction between VP and vasodilators in the RA is un-
known.
The present study was designed to compare the contrac-
tile effect of VP in the RA and ITA. In addition, the effects
of milrinone (MIL), nitroglycerin (NTG), and nitroprusside
(SNP) were also studied in the VP-induced contraction in
the RA and the ITA.
Methods
General Techniques
Human ITA (n  122 from 35 patients) and RA segments (n 
107 from 31 patients) were collected from the patients undergoing
CABG. Approval to use discarded vessel tissues was granted by
the Institutional Review Board at Providence St Vincent Hospital.
The discarded artery segments were collected and placed in a
container with oxygenated physiologic solution (Krebs solution)
maintained at 4°C and transferred to the laboratory immediately.
The vessels were carefully cleaned of connective tissue and cut
into 3-mm long rings. The rings were suspended on wires in
20-mL organ baths filled with Krebs solution maintained at 37°C
and continuously aerated with a mixture of 95% oxygen and 5%
carbon dioxide. The modified Krebs solution had the following
composition (millimolar): Na 144, K 5.9, Ca2 2.5, Mg2 1.2,
Cl 128.7, HCO3 25, SO42 1.2, H2PO4 1.2, and glucose 11.
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A technique that allowed for vessel rings to normalize to a phys-
iologic pressure in the organ bath was used in this study. Artery
rings were set at a pressure comparable to that in the in vivo
situation. The details of the technique have been published13,14 and
repeatedly used in our in vitro studies for human vessels.12,15,16 In
brief, two parallel stainless-steel L-shaped wire hooks (440 m in
diameter) were introduced through the lumen of the artery ring.
The lower hook was fixed to a micrometer-adjustable support leg,
and the upper hook was fixed to an isometric force transducer
(model FT03, Grass Instrument Company, West Warwick, RI) to
record changes in isometric force, which was amplified and re-
corded on a polygraph chart recorder (model 79H, Grass Instru-
ment Company). The rings were stretched up in progressive steps
to determine the length-tension curve for each ring. A computer
iterative fitting program (Vastand 2.1; Yang-Hui He, Princeton,
NJ) was used to determine the exponential line, pressure, and
internal diameter. When the transmural pressure on the rings
reached 100 mm Hg, as determined from their own length-tension
curves, the stretch-up procedure was stopped, and the rings were
released to 90% of their internal circumference at 100 mm Hg.
This degree of passive tension was then maintained throughout the
experiment. After the normalization procedure, the ITA or RA
rings were equilibrated for at least 45 minutes.
In this study, the endothelium was intentionally preserved by
cautiously dissecting and mounting the rings because endothelium
plays a modulation role in the contractility and relaxation of
arterial graft. We have found that this technique allows for the
experiments to be performed with an intact endothelium, as deter-
mined by the functional relaxation response to acetylcholine or
calcium ionophore in the human arteries.13,15
Protocol
Ring segments from the same patient were divided into 4 groups,
which were randomly allocated into the 4-organ bath arrangement
running concurrently.
Relaxation of Vasopressin-Induced Contraction by
Milrinone, Nitroglycerin, and Nitroprusside
The EC10  EC90 of VP was previously determined from the
logistic curve-fitting equation for ITA12 and pilot experiments for
RA. VP at 8.5 log10M and 9.0 log10M induced 60% to 80% of
the maximum contractile response in the ITA and RA ring seg-
ments, respectively, and these concentrations were used for pre-
contraction of the vessels before relaxation. Cumulative concen-
tration-relaxation curves to MIL, NTG, and SNP (10 log10M–
4.5 log10M) were then established.
Depression of Vasopressin-Induced Contraction by
Pretreatment with Milrinone, Nitroglycerin, and
Nitroprusside
After equilibration, KCl (0.1 mol/L) was added to the organ bath,
and the contraction force was recorded. The rings were then
repeatedly washed with Krebs solution (at least 3 times) to restore
the baseline. Subsequently, the vessels were incubated with MIL,
NTG, or SNP for at least 10 minutes before the VP contraction was
evoked. During the whole contraction experiments, the vasodilator
was present in the bath to simulate the clinical setting under which
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Pthe vasodilator was administrated intravenously to reach the
plasma concentration we used in the bath. The contraction was
expressed as the percentage of the maximum contraction force
induced by 0.1 mol/L K. The advantage of this expression is to
normalize the contraction by the response to a standard vasocon-
strictor to eliminate the possible differences caused by other fac-
tors. To be sure of the validity of the comparison among the
arteries treated with different concentrations of the vasodilator,
each artery was cut into 3 (for MIL study) or 4 (for SNP and NTG
studies) rings, allocated for each treatment. There was always 1
ring taken from the same segment of the vessel that was set as the
control for the rings treated with vasodilators to eliminate the
possible influence by other factors.
The concentration of MIL (5.15 log10M) and NTG (7
log10M) for the pretreatment was similar to the optimum thera-
peutic free plasma concentration reached clinically.17,18 Therapeu-
tic free plasma concentration of SNP was not available; therefore,
the same concentration used for NTG was chosen for the study.
The supraclinical concentrations were also studied because these
concentrations could be reached topically during CABG.
Data Analysis
The sensitivity of both vasoconstrictor and vasodilator substances
was expressed as EC50, the effective concentration that caused
50% of maximal contraction or relaxation. The EC50 was deter-
mined from each concentration-contraction (or relaxation) curve
by a logistic, curve-fitting equation: E  MAP/(APKP) where E
is response, M is maximal contraction or relaxation, A is concen-
tration, K is EC50 concentration, and P is the slope parameter.13 A
computerized program was used for the curve fitting.
All results were expressed as mean  SEM. The data were
analyzed by analysis of variance (ANOVA) and Dunnett’s post
hoc comparison19 for comparing several treatment groups with a
control and by unpaired t test for comparing between 2 indepen-
dent groups.
In this study, “sensitivity” is used to describe the location of the
concentration-response curve and is measured by the EC50 value;
“reactivity” describes the range of response and is measured as the
maximum relaxation or contraction.
Drugs
NTG and SNP were purchased from Abbott Laboratories (Chi-
cago, Ill). MIL was generously provided as a gift by Sterling-
Winthrop Pharmaceutical Research Division (Rensselear, NY).
Arginine VP was ordered from Sigma Chemical Co (St Louis,
Mo).
Results
Vasopressin-Induced Contraction in the Internal
Thoracic Artery and Radial Artery
The diameter at a pressure of 100 mm Hg (D100) was 3.01
 0.05 mm for the RA and 2.6  0.04 mm for the ITA (P
 .001). VP invoked a stronger contraction force in the RA
than in the ITA (maximal contraction: 16.4  1.2 g, n  17
vs 5.0  0.7 g, n  25; P  .001, Figure 1, b). Moreover,
when normalized as force gram produced by each millime-
ter of the circumference tissue of the artery, the contraction
The Journal of Thorac(gram/millimeter) was still significantly greater in the RA
than in the ITA (1.8  0.2 g/mm vs 0.6  0.1 g/mm, P 
.001). The EC50 was significantly lower in the RA than in
the ITA (9.28 0.11 vs8.91 0.05 log10M, P .006)
(Figure 1), and this reveals higher sensitivity of the RA to
VP.
Relaxation of Vasopressin-Induced Contraction by
Milrinone, Nitroglycerin, and Nitroprusside
In the ITA, the maximum relaxation caused by MIL, NTG,
and SNP was 96.2%  2.0%, 92.6%  2.8%, and 91.2% 
3.8%, respectively (P  .7  1.0; Figure 2). The EC50 for
NTG (7.40  0.12 log10M) was lower than that for SNP
(6.51  0.16 log10M, 95% confidence interval [CI]: 0.74-
1.64, P  .001) and MIL (6.21  0.12 log10M, 95% CI:
0.44-1.34, P  .001), indicating that the sensitivity of the
vessel to NTG is the highest among the 3 vasodilators.
In the RA, the maximum relaxation caused by MIL
(73.7%  3.4%) was significantly less than that of NTG
(95.1%  1.6%, 95% CI: 3.47-31.7, P  .02) and SNP
98.6%  0.7%, 95% CI: 2.56-29.5, P  .02). The EC50
Figure 1. a, Mean concentration-contraction (percentage of 0.1
mol/L K-induced contraction) curves for VP in the ITA (n  25)
and RA (n 17). b, Maximal contraction force (gram). c, Maximal
contraction normalized as force gram per each millimeter of the
circumference of the artery (gram/mm). Data are shown as mean
 SE (*P< .001, unpaired t test). ITA, Internal thoracic artery; RA,
radial artery.for MIL (5.44  0.07 log10M) was higher than that for
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CSPNTG (6.48  0.22 log10M, 95% CI: 1.67-0.37, P 
.003) and SNP (6.60  0.14 log10M, 95% CI: 1.77-
0.47, P  .001; Figure 2), also indicating the decreased
sensitivity of the vessel to MIL compared with the other
2 vasodilators.
Depression of Contraction to Vasopressin by
Pretreatment with Milrinone, Nitroglycerin, and
Nitroprusside
Effect of milrinone. In the ITA, pretreatment with MIL
at 5.15 log10M and 4.15 log10M significantly inhibited
VP contraction (P  .001 vs the control, 2-way ANOVA)
(Figure 3 and Table 1). Pretreatment of MIL (4.15 log10M
and 5.15 log10M) significantly inhibited the maximum
contraction to VP (36.2%  7.6%, P  .001 and 73.2% 
14.5%, P .001 vs 119.3% 13.1% in the control) (Figure
3, a). In contrast, in the RA, MIL did not significantly
change the maximum contraction to VP (P  .85  .96,
Figure 3, b). In regard to the EC50, MIL (4.15 log10M)
significantly decreased the sensitivity (increased EC50) for
the VP contraction in the ITA and RA compared with the
control (Figure 3 and Table 1).
Effect of nitroprusside. In the ITA, pretreatment with
SNP at 6 log10M (P  .008) and 4.5 log10M (P  .01)
significantly inhibited VP-induced contraction versus the
control (2-way ANOVA, Figure 4 and Table 1). SNP (6
and 4.5 log10M) significantly reduced the maximum con-
traction by VP (47.6%  8.8%, P  .006 and 54.8% 
17.3%, P  .02 vs 114.3%  13.6% in the control). In
contrast, SNP did not significantly reduce the maximum
contraction to VP in the RA compared with the control (P
.4  1.0). In addition, SNP did not significantly change the
EC50 for the VP contraction in either the ITA or RA (P 
.4  1.0, Table 1). However, at the lower concentration of
Figure 2. Mean concentration-response (percentage o
in the ITA (a, n  10 in each group) and RA (b, n  9
**P < .01 vs NTG, 1-way ANOVA). MIL, Milrinone; SNVP (10.5–9 log10M), SNP at 6 and 4.5 log10M
36 The Journal of Thoracic and Cardiovascular Surgery ● Januasignificantly inhibited the contraction in the RA compared
with the control (P  .02  .005) (Figure 4).
Effect of nitroglycerin. Pretreatment with NTG did not
significantly inhibit the maximum contraction induced by
VP in either the ITA or the RA (P  .4  .98, Figure 5 and
Table 2). However, NTG significantly increased the EC50
for the VP contraction in the ITA compared with the control
(P  .02). In contrast, in the RA, the EC50 was not signif-
icantly different among the groups (P .6 1.0). At lower
concentrations of VP (10.5–9.5 log10M), pretreatment
with NTG at 6 and 4.5 log10M significantly inhibited
the contraction compared with the control (P  .03  .002)
(Figure 5 and Table 1).
Discussion
This study demonstrated the following: (1) The RA is more
sensitive and develops a stronger contraction to VP than the
ITA; (2) MIL is effective in both reversing and preventing
the VP contraction in the ITA, but in the RA either its
relaxation or its effect in prevention of VP contraction is
limited; (3) SNP and NTG may act differently in preventing
the VP contraction in the ITA: SNP significantly depressed
the maximum contraction, whereas NTG only significantly
reduced the sensitivity; and (4) both NTG and SNP effec-
tively reverse the VP contraction in the RA but had little
effect on prophylaxis.
Similar to the ITA, the RA has recently been reported to
have superior long-term patency5 to the saphenous vein.1
However, the use of the RA is compromised by its relatively
higher incidence of vasospasm.2,3,15 Further, the 5-year
patency rate of the RA (83%) is less than that of the ITA
(91%),5 and this may indicate that further improvement of
the method to control vasospasm in the RA is necessary.
In the present study, the RA was found to have a larger
rsal of VP contraction) curves for MIL, SNP, and NTG
ch group). Data are shown as mean  SE (*P < .05,
troprusside; NTG, nitroglycerin.f reve
in eadiameter than the ITA, which is favorable for its use in
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PCABG. However, the RA presents a significantly stronger
and more sensitive (lower EC50) contractile response to VP
than the ITA (Figure 1). These results are in accordance
with our previous study,15 as well as with another study,6 in
which the RA has higher receptor-mediated contractility
compared with the ITA. It has been demonstrated that there
is higher density of smooth muscle cells in the media of the
RA wall compared with the ITA,20,21 and the stronger
VP-induced contraction in the RA may be related to this
anatomic feature. Moreover, the myocytes are organized
into multiple tight layers in the RA, whereas the muscle
cells are less organized and loose in shape in the ITA.21
Another possibility is that the density of the VP receptors in
Figure 3. Mean concentration-contraction (percentage
ITA (a, n  8 in each group) and RA (b, n  8 in
concentration). Data are shown as mean SE (*P< .0
TABLE 1. Inhibitory effect of MIL, SNP, and NTG on ma
contraction force) and EC50 of VP-induced contraction in t
ITA
Log10M
Maximal
contraction
(%) P value
EC50
(log10M)
MIL (n  8) .000
Control 119.3 13.1 8.88 0.04
5.15 73.2 14.5* 8.74 0.05
4.15 36.2 7.6** 8.55 0.06**
SNP (n  8) .005
Control 114.3 13.6 8.79 0.07
7 100.4 16.5 8.67 0.12
6 47.6 8.8** 8.66 0.06
4.5 54.8 17.3* 8.52 0.09
NTG (n  9) .57
Control 155.4 20.3 9.04 0.09
7 116.4 17.3 8.75 0.05*
6 108.6 28.2 8.76 0.06*
4.5 124.4 29.5 8.76 0.07*
VP, Vasopressin; MIL, milrinone; SNP, nitroprusside; NTG, nitroglycerin; IT
P values are compared among the groups; *P  .05; **P  .01 vs the cothe RA may be different than that in the ITA. The signifi-
The Journal of Thoraccantly increased plasma level of VP during CABG indicates
that VP may be a potential risk factor leading to vasospasm
of the RA in CABG perioperatively.
As a phosphodiesterase inhibitor, MIL is a noncat-
echolamine, nonglycosidic inotropic agent with vasodilator
activity.22 Cardiac contraction and vascular smooth muscle
relaxation are related to the biologic activity of second
messengers such as cyclic adenosine monophosphate and
cyclic guanosine monophosphate, which are hydrolyzed by
phosphodiesterases.23 The positive inotropic and vasodila-
tor effect of phosphodiesterase inhibitors may therefore be
particularly indicated in patients during CABG.24-26 There-
fore we have systematically studied the role of MIL in the
.1 mol/L K-induced contraction) curves for VP in the
group) with or without pretreatment of MIL (log M
< .001 vs the control; 1-way ANOVA). MIL, Milrinone.
al contraction (percentage of the 0.1 mol/L K-induced
A and RA
RA
alue
Maximal
contraction
(%) P value
EC50
(log10M) P value
01 .97 .005
242.0 20.6 9.26 0.09
234.2 22.6 9.04 0.09
242.8 40.6 8.77 0.11**
.53 .1
228.7 19.8 9.26 0.21
226.2 26.0 9.21 0.16
201.1 20.6 8.89 0.12
190.3 20.3 8.75 0.14
15 .94 .17
226.3 21.7 9.27 0.22
221.5 22.9 8.96 0.15
204.9 16.5 9.02 0.14
214.0 35.6 8.73 0.14
ternal thoracic artery; RA, radial artery; ANOVA, analysis of variance.
(1-way ANOVA).of 0
eachxim
he IT
P v
.0
.2
.0
A, inhuman coronary bypass conduits,24-26 including the RA.26
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CSPIn the present study, it was found that MIL had a superior
effect in the ITA than in the RA. MIL induced a full
relaxation in the ITA but had only a submaximal effect in
the RA (Figures 2 and 3). This shows that MIL has a
vessel-selective effect. Further, regarding the prevention of
the VP-induced contraction, MIL had a significant effect in
the ITA but only little effect in the RA. This further shows
the vessel-selective effect of MIL.
Notably, even in the same artery (in both the ITA and
RA), the effect of MIL on the VP-induced vasoconstriction
is different between the relaxation and the prevention of the
relaxation. At the concentration of 4.5 log M, MIL in-
duced 100% relaxation in the ITA (Figure 2, a), but when it
is used before the contraction to VP at an even higher
concentration (4.15 log M), the ITA can still contract to
approximately 40% of the maximum contraction (Figure 3,
a). This phenomenon is more significant in the RA, in which
Figure 4. Mean concentration-contraction (percentage
ITA (a, n  8 in each group) and RA (b, n  7 in e
concentration). Data are shown as mean  SE (*P
Nitroprusside.
Figure 5. Mean concentration-contraction (percentage
ITA (a, n  9 in each group) and RA (b, n  7 in e
concentration). Data are shown as mean  SE (*P <the maximum contraction to VP was not affected by the
38 The Journal of Thoracic and Cardiovascular Surgery ● Januapretreatment of MIL, although the “sensitivity” to VP was
increased by the pretreatment (Table 1 and Figure 3, b).
In previous studies, we have found that vasodilators such
as MIL25,26 and NTG27 are potent in reversing existing
vascular contraction but less effective if applied before the
contraction. As described by Maurice and colleagues,28
there may be critical differences in the state of the vascular
smooth muscle before and after induction of contraction that
affect the responses to vasodilator substances. Increases in
intracellular Ca2 concentration and the phosphorylation of
myosin light chain are important in the contraction of vas-
cular smooth muscle29; therefore, compounds that block
these processes will inhibit contraction. However, relax-
ation of smooth muscle that involves reversal of a latch state
is less dependent on the inhibition of Ca2 mobilization or
on dephosphorylation of myosin.30
In the present study it was also observed that, to some
.1 mol/L K-induced contraction) curves for VP in the
group) with or without pretreatment of SNP (log M
05, **P < .01 vs the control; 1-way ANOVA). SNP,
.1 mol/L K-induced contraction) curves for VP in the
group) with or without pretreatment of NTG (log M
s the control; 1-way ANOVA). NTG, Nitroglycerin.of 0
ach
< .of 0
achextent, NTG and SNP acted differently against VP-mediated
ry 2005
Wei et al Cardiopulmonary Support and Physiology
CS
Pcontraction in the ITA. Although both NTG and SNP had an
almost full relaxation in VP-mediated contraction in the ITA,
when used before the contraction (pretreatment) SNP signifi-
cantly inhibited the maximum VP-induced contraction with
little effect on EC50. In contrast, NTG significantly reduced the
sensitivity to VP (increased EC50) without reducing the max-
imum contraction (Table 2 and Figures 4 and 5). These find-
ings are in agreement with previous studies.7,24 In addition to
the aforementioned mechanisms, this could be explained by
the rapidly developed NTG tolerance (tachyphylaxis),24,27,31
whereas the inhibitory effect of SNP is only marginally sup-
pressed in arteries that tolerate NTG.32 Further, with regard to
the decreased potency in preventing contraction by NTG, an-
other possible reason could be that NTG is a short-lived drug.
After a 10-minute incubation, although the intention was to
keep the drug in the bath, it is unknown what concentration of
NTG was left in the bath and what percentage of NTG was
metabolized.
On the other hand, both NTG and SNP had a similar
relaxant effect in the RA compared with the ITA but a
limited effect in inhibiting VP-induced contraction, further
demonstrating the differences between the RA and ITA.
Conclusion
The present study demonstrates that the RA has greater
(VP) receptor-mediated contractility than the ITA and is
more prone to vasospasm mediated by VP. Both MIL and
nitrovasodilators may effectively reverse the VP-mediated
contraction in both the ITA and RA. MIL and SNP may be
used for prophylaxis against VP-induced contraction in the
ITA, but they have limited effect in the RA. This study
emphasizes more intensive treatment against VP-mediated
vasospasm in the RA during CABG.
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